Key facts
- PFM Health Sciences, LP filed SCHEDULE 13G/A for PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2025.
PFM Health Sciences, LP - 30 Jun 2025 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP)
- Filing Manager
- PFM Health Sciences, LP
- Reporting Manager
- PFM Health Sciences, LP
- Symbol
- PMVP
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:02:29 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
PFM Health Sciences, LP disclosed 0% ownership in PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP) on 30 Jun 2025.
Change
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Aug 2025, 16:02.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (4)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PFM Health Sciences, LP | 0% | 0 | 0 | 0 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| PFM Health Sciences GP, LLC | 0% | 0 | 0 | 0 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Partner Asset Management, LLC | 0% | 0 | 0 | 0 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Brian D. Grossman | 0% | 0 | 0 | 0 | /s/ Darren Mooney | Darren Mooney, attorney-in-fact* |
CIK / CUSIP context first